AstraZeneca commits $50 billion to US pharmaceutical manufacturing and R&D The investment covers projects across the country, led by a drug substance production facility in Virginia.

NewBiologix was founded with a mission to revolutionize production of adenoassociated virus (AAV) vectors, focusing on high quality and reduced risk in both manufacturing and patient treatment.

Presented are highlights of the manufacturing trends that have reshaped the capacity landscape to our current state and explore the potential impact of currently developing events on both supply and ...